Biography:
Elizabeth Dale Gilley is a research scientist who focuses upon underlying neurogenetic and neurobiological syndrome which manifest as Substance Use Disorders and comorbid Mental Health Disorder Clusters. The Elle Foundation 100 series in family genomics clearly demonstrates the Reward Deficiency Syndrome paradigm and how genomic applications benefit RDS families over the generations. She is in her 6th year of longitudinal studies for the 100s series. She is in the data collection analysis phase of the 200s series, which will inform the design of a much larger study known as the EF300s.
Title : Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Title : Psychostimulants for children: Are we over or under dosing?
Title : The future is now for precision genomic addiction medicine as a frontline modality for inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
Title : Precision genomic addiction medicine as a frontline modality as a function of inducing “dopamine homeostasis” in reward deficiency syndrome (RDS): The future is now
Title : Integrating the Science of Addiction and the Science of Wellbeing